The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akash Sethi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 1.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter and Managing Director Akash Sethi acquired 75,150 equity shares of Shree Pacetronix Limited on March 20, 2026, by converting warrants that were originally issued under a preferential allotment. This represents 2% of the expanded share capital. His direct equity holding rose from 87,966 to 1,63,116 shares (4.35% of expanded equity capital), while his total holding including 1,50,300 remaining unconverted warrants stands at 3,13,416 shares, equating to 8.04% of the fully diluted share capital. The company's total equity share capital increased from ₹3.67 crore (36,74,550 shares) to ₹3.75 crore (37,49,700 shares) as a result of this conversion.
This is a positive signal as the promoter is increasing his stake in the company, showing confidence in the business. However, since the acquisition is through warrant conversion rather than an open market purchase, the direct impact on share price may be limited. Existing shareholders may see this as a sign of promoter commitment to long-term growth.